FI874710A - Nya farmaceutiska sammansaettningar foer inhalation. - Google Patents

Nya farmaceutiska sammansaettningar foer inhalation. Download PDF

Info

Publication number
FI874710A
FI874710A FI874710A FI874710A FI874710A FI 874710 A FI874710 A FI 874710A FI 874710 A FI874710 A FI 874710A FI 874710 A FI874710 A FI 874710A FI 874710 A FI874710 A FI 874710A
Authority
FI
Finland
Prior art keywords
inhalation
nya
foer
pharmaceutical
sammansaettningar
Prior art date
Application number
FI874710A
Other languages
English (en)
Other versions
FI90015C (fi
FI874710A0 (fi
FI90015B (fi
Inventor
Paolo Chiesi
Luciana Pavesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of FI874710A publication Critical patent/FI874710A/fi
Publication of FI874710A0 publication Critical patent/FI874710A0/fi
Application granted granted Critical
Publication of FI90015B publication Critical patent/FI90015B/fi
Publication of FI90015C publication Critical patent/FI90015C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
FI874710A 1986-03-04 1987-10-26 Fyllnadsaemne och dess anvaendning i farmaceutiska sammansaettningar foer inhalation FI90015C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT1962586 1986-03-04
IT19625/86A IT1204826B (it) 1986-03-04 1986-03-04 Composizioni farmaceutiche per inalazione
EP8700118 1987-02-27
PCT/EP1987/000118 WO1987005213A1 (en) 1986-03-04 1987-02-27 New pharmaceutical compositions for inhalation

Publications (4)

Publication Number Publication Date
FI874710A true FI874710A (fi) 1987-10-26
FI874710A0 FI874710A0 (fi) 1987-10-26
FI90015B FI90015B (fi) 1993-09-15
FI90015C FI90015C (fi) 1993-12-27

Family

ID=11159814

Family Applications (1)

Application Number Title Priority Date Filing Date
FI874710A FI90015C (fi) 1986-03-04 1987-10-26 Fyllnadsaemne och dess anvaendning i farmaceutiska sammansaettningar foer inhalation

Country Status (17)

Country Link
EP (2) EP0258356B1 (fi)
JP (1) JPS63502895A (fi)
KR (1) KR940000099B1 (fi)
AT (1) ATE94755T1 (fi)
AU (1) AU597964B2 (fi)
CA (1) CA1297012C (fi)
DE (2) DE3787502T2 (fi)
ES (1) ES2031839T3 (fi)
FI (1) FI90015C (fi)
GR (2) GR880300017T1 (fi)
HU (1) HU202748B (fi)
IT (1) IT1204826B (fi)
MY (1) MY102928A (fi)
NO (1) NO874590L (fi)
NZ (1) NZ219484A (fi)
WO (1) WO1987005213A1 (fi)
ZA (1) ZA871523B (fi)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208226A (en) * 1989-09-08 1993-05-04 Glaxo Group Limited Medicaments
US5270305A (en) * 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
US5376386A (en) * 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
JPH0558911A (ja) * 1991-08-27 1993-03-09 N D Shinyaku Kaihatsu Kenkyusho:Kk 鎮咳去痰剤
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
AUPM411494A0 (en) * 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
US6503537B2 (en) * 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6599883B1 (en) * 1998-10-30 2003-07-29 Nastech Pharmaceutical Company, Inc. Nasal delivery of xylitol
DK1283036T3 (da) 1998-11-13 2008-03-25 Jagotec Ag Törpulver til inhalation
SK286981B6 (sk) * 1999-03-05 2009-08-06 Chiesi Farmaceutici S.P.A. Prášok na použitie v inhalátore na suché prášky, nosič na tento prášok a spôsob výroby prášku
ITMI991582A1 (it) 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
ES2632461T3 (es) 2000-06-27 2017-09-13 Vectura Limited Formulaciones para su uso en dispositivos inhaladores
DE60131399T3 (de) * 2000-06-27 2019-11-14 Vectura Ltd. Herstellungsverfahren für partikel zur verwendung in einer arzneizusammensetzung
EP1337241B1 (en) † 2000-11-30 2008-01-02 Vectura Limited Method of preparing microparticles for use in pharmaceutical compositions for inhalation
EP2168571B1 (en) 2000-11-30 2018-08-22 Vectura Limited Particles for use in a Pharmaceutical Composition
EP1920763B2 (en) 2000-11-30 2022-06-15 Vectura Limited Pharmaceutical compositions for inhalation
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
DE10141376A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
AU2002333644A1 (en) 2001-09-17 2003-04-01 Glaxo Group Limited Dry powder medicament formulations
EP1417961A1 (en) * 2002-11-08 2004-05-12 Boehringer Ingelheim International GmbH New pharmaceutical compositions containing a combination of ambroxol or bromhexine and isopropamide iodide
WO2005004845A1 (en) 2003-07-11 2005-01-20 Glaxo Group Limited Pharmaceutical formulations comprising magnesium stearate
PE20050250A1 (es) 2003-07-17 2005-04-08 Glaxo Group Ltd Antagonistas de los receptores muscarinicos de la acetilcolina
ATE494285T1 (de) 2003-10-14 2011-01-15 Glaxo Group Ltd Muscarinische acetylcholin-rezeptor-antagonisten
AP2006003575A0 (en) 2003-10-17 2006-04-30 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists.
TW200524577A (en) 2003-11-04 2005-08-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
GB0326632D0 (en) 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
EP1725564A4 (en) 2004-03-17 2007-09-12 Glaxo Group Ltd ANTAGONISTS OF THE M3 MUSCARIN ACETYL CHOLIN RECEPTOR
AR050902A1 (es) 2004-04-27 2006-12-06 Glaxo Group Ltd Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion
EP1747219A4 (en) 2004-05-13 2010-05-26 Glaxo Group Ltd Antagonists of muscarinic acetylcholine receptor
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
KR101488403B1 (ko) 2005-05-18 2015-02-04 엠펙스 파마슈티컬즈, 인코포레이티드 에어로졸화된 플루오로퀴놀론 및 이의 용도
WO2007022351A2 (en) 2005-08-18 2007-02-22 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
GB0525254D0 (en) 2005-12-12 2006-01-18 Jagotec Ag Powder compositions for inhalation
US7832397B2 (en) 2005-12-28 2010-11-16 Philip Morris Usa Inc. Aerosol powder delivery device
GB0605723D0 (en) 2006-03-23 2006-05-03 3M Innovative Properties Co Powder filling processes
US8815838B2 (en) 2008-10-07 2014-08-26 David C. Griffith Aerosol fluoroquinolone formulations for improved pharmacokinetics
PL2346509T3 (pl) 2008-10-07 2021-03-08 Horizon Orphan Llc Lewofloksacyna w postaci aerozolu dla zmniejszania stanu zapalnego płuc
DK2400950T3 (da) 2009-02-26 2019-07-29 Glaxo Group Ltd Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
MX353288B (es) 2009-09-04 2018-01-08 Raptor Pharmaceuticals Inc Uso de levofloxacina aerosolizada para el tratamiento de fibrosis quistica.
GB0918249D0 (en) 2009-10-19 2009-12-02 Respivert Ltd Compounds
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
SI2560611T1 (en) * 2010-04-21 2018-03-30 Chiesi Farmaceutici S.P.A. A process for preparing particles with reduced electrostatic charges
TR201007250A2 (tr) 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Selobioz içeren formülasyon.
UY33337A (es) 2010-10-18 2011-10-31 Respivert Ltd DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS
ES2913095T3 (es) 2011-01-31 2022-05-31 Avalyn Pharma Inc Compuestos de pirfenidona y análogos de piridona en aerosol y usos de los mismos
NZ628072A (en) 2012-03-13 2015-08-28 Respivert Ltd Crystalline pi3 kinase inhibitors
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
US10370183B2 (en) 2012-07-19 2019-08-06 Adamis Pharmaceuticals Corporation Powder feeding apparatus
GB201305825D0 (en) * 2013-03-28 2013-05-15 Vectura Ltd New use
CA2919498C (en) 2013-07-31 2023-07-25 Windward Pharma, Inc. Aerosol nintedanib compounds and uses thereof
WO2015106150A1 (en) 2014-01-10 2015-07-16 Genoa Pharmaceuticals Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
DE102016218604A1 (de) 2016-09-27 2018-03-29 Constantin Adams Partikuläres Stoffgemisch, vorzugsweise zur Verwendung bei der Prophylaxe und/oder Behandlung einer Atemwegsstörung
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
WO2023028364A1 (en) 2021-08-27 2023-03-02 Sepelo Therapeutics, Llc Targeted compositions and uses therof
WO2023128916A1 (en) * 2021-12-31 2023-07-06 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi An apparatus with a grid (10) for the preparation of dry powder compositions for inhalation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
DE3012136C2 (de) * 1980-03-28 1984-02-16 Bauer, Kurt Heinz, Prof. Dr., 7800 Freiburg Verfahren zur Herstellung eines Granulats

Also Published As

Publication number Publication date
NO874590D0 (no) 1987-11-03
KR880700666A (ko) 1988-04-11
DE3787502D1 (de) 1993-10-28
CA1297012C (en) 1992-03-10
FI90015C (fi) 1993-12-27
AU597964B2 (en) 1990-06-14
MY102928A (en) 1993-03-31
ES2031839T3 (es) 1993-01-01
HU202748B (en) 1991-04-29
EP0239798A1 (en) 1987-10-07
ZA871523B (en) 1987-08-24
ATE94755T1 (de) 1993-10-15
EP0258356B1 (en) 1993-09-22
JPS63502895A (ja) 1988-10-27
GR880300017T1 (en) 1988-10-18
KR940000099B1 (ko) 1994-01-05
DE258356T1 (de) 1988-09-01
EP0258356A1 (en) 1988-03-09
AU7164587A (en) 1987-09-28
IT8619625A0 (it) 1986-03-04
NZ219484A (en) 1989-10-27
GR3000879T3 (en) 1991-11-15
WO1987005213A1 (en) 1987-09-11
IT1204826B (it) 1989-03-10
HUT46533A (en) 1988-11-28
EP0239798B1 (en) 1990-09-26
FI874710A0 (fi) 1987-10-26
NO874590L (no) 1987-12-30
DE3787502T2 (de) 1994-01-20
FI90015B (fi) 1993-09-15

Similar Documents

Publication Publication Date Title
FI874710A (fi) Nya farmaceutiska sammansaettningar foer inhalation.
ATE66143T1 (de) Feste zubereitung mit langsamer freisetzung.
NO900533D0 (no) Forbindelse for smoeremiddelsammensetninger, smoeremiddelsammensetning-konsentrat og fremgangsmaate for fremstilling av sammensetningen.
GB8501015D0 (en) Drug
NO862650L (no) Fremgangsmaate for fremstilling av isoksazol- og furanderivater.
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
ATE109783T1 (de) 23-oxo(keto) und 23-imino-derivate von ll-f28249- verbindungen.
NO872712L (no) FremgangsmŸte for fremstilling av kalsiumholdige preparater.
IT8522668A0 (it) Procedimento per la preparazione di (2,2)-paraciclofani alogenati e miscele di (2,2)-paraciclofani alogenati ottenuti.
NO880179D0 (no) Polymerkomplekser, fremgangsmaate for fremstilling av disse, og farmasoeytiske midler inneholdende disse.
ES2012339B3 (es) Preparacion oral de ajo y procedimiento para su fabricacion
NO873454L (no) Fremstilling og anvendelse av faste fytoaktive blandinger.
DE3885031T2 (de) Wasserlösliches antibiotisches Präparat und wasserlösliche Salze von Cephem-Verbindungen.
DE3786562T2 (de) 2,6-Dideoxy-2-fluoro-L-talopyranose, Derivate davon und Herstellung dieser Verbindungen.
ES511730A0 (es) "un procedimiento para la preparacion de oxaprocin calcico".
ATE96802T1 (de) 23-oxo (keto) und 23-imino-derivate von monound diepoxy ll-f28249 verbindungen.
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
EP0199085A3 (en) Jomol, its derivatives, process for the preparation of these substances, their use and their production
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
IL79965A0 (en) Pharmaceutical composition comprising an angiotensin converting enzyme inhibitor for the treatment of high blood pressure
ATE47863T1 (de) Makrolide derivate.
FI891898A (fi) HIV-1:een liittyvät polypeptidit, diagnostiset systeemit ja analyysimenetelmät
KR900700471A (ko) 신규의 2,3-티오모르폴린디온-2-옥심유도체, 이들을 함유하는 약제학적 조성물 및 제법
DK363985A (da) Antineoplastisk middel
DK511687D0 (da) Farmaceutisk praeparat, samt fremstilling og anvendelse heraf

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: CHIESI FARMACEUTICI S.P.A.